Endothelial nitric oxide synthase/soluble guanylate cyclase system in human nasal polyps

被引:8
|
作者
Escobar, P
Márquez, FJ
Carrasco, C
Alonso-Orgaz, S
Fortes, J
Cenjor, C
López-Farré, A
机构
[1] Hosp Clin San Carlos, Cardiovasc Inst, Madrid 28040, Spain
[2] Fdn Jimenez Diaz, Dept Otorhinolaryngol, E-28040 Madrid, Spain
关键词
cyclic GMP; endothelium; guanylate cyclase; nitric oxide; nasal mucosa; polyps;
D O I
10.1007/s00405-004-0857-2
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
The aim of our study was to analyze the level of expression of the endothelial nitric oxide synthase (eNOS)/soluble guanylate cyclase (sGC) system in nasal polyps and control nasal mucosae. The study was performed in polyps from 15 patients and nasal mucosae from 11 subjects operated on the nasal septum (control group). The expression of endothelial nitric oxide synthase (eNOS) and soluble guanylate cyclase (sGC) was determined in nasal mucosae. Western blot analysis demonstrated that eNOS protein was overexpressed in the nasal polyps with respect to control nasal mucosae. Immunohistochemistry also demonstrated that the vascular endothelium of nasal polyps contained higher amounts of eNOS protein than control nasal mucosae. Moreover, the beta(1) subunit of sGC was also overexpressed in the nasal polyps, which was associated with an increased content of cyclic GMP in the nasal polyps with respect to nasal control mucosae. In human nasal polyposis, there is an overexpression of the eNOS/sGC system. Further studies are needed to assess whether this overexpression is involved in the genesis of nasal polyposis.
引用
收藏
页码:512 / 516
页数:5
相关论文
共 50 条
  • [41] Ambroxol as an inhibitor of nitric oxide-dependent activation of soluble guanylate cyclase
    Severina, IS
    Bussygina, OG
    Pyatakova, NV
    Khropov, YV
    Krasnoperov, RA
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 407 (1-2) : 61 - 64
  • [42] Alterations in soluble guanylate cyclase content and modulation by nitric oxide in liver disease
    Rodrigo, R
    Montoliu, C
    Chatauret, N
    Butterworth, R
    Behrends, S
    Del Olma, JA
    Serra, MA
    Rodrigo, JA
    Erceg, S
    Felipo, V
    NEUROCHEMISTRY INTERNATIONAL, 2004, 45 (06) : 947 - 953
  • [43] DEVELOPMENT OF A NOVEL BIOLUMINESCENT ASSAY FOR NITRIC OXIDE BY USING SOLUBLE GUANYLATE CYCLASE
    Sano, Yoshihiro
    Seki, Masayuki
    Suzuki, Shigeya
    Abe, Seiji
    Ito, Katsutoshi
    Arakawa, Hidetoshi
    BIOLUMINESCENCE AND CHEMILUMINESCENCE: LIGHT EMISSION: BIOLOGY AND SCIENTIFIC APPLICATIONS, 2009, : 109 - 112
  • [44] The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase
    Benza, Raymond L.
    Gruenig, Ekkehard
    Sandner, Peter
    Stasch, Johannes -Peter
    Simonneau, Gerald
    EUROPEAN RESPIRATORY REVIEW, 2024, 33 (171):
  • [45] Is the soluble guanylate cyclase pathway the only one available for nitric oxide (NO) signaling?
    Landar, Aimee
    Darley-Usmar, Victor M.
    IUBMB LIFE, 2007, 59 (02) : 110 - 112
  • [46] Altered Modulation of Soluble Guanylate Cyclase by Nitric Oxide in Patients with Liver Disease
    R. Corbalán
    C. Montoliu
    M. D. Miñana
    J. A. Del Olmo
    M. A. Serra
    L. Aparisi
    J. M. Rodrigo
    V. Felipo
    Metabolic Brain Disease, 2002, 17 : 295 - 301
  • [47] Development of a novel bioluminescent assay for nitric oxide using soluble guanylate cyclase
    Sano, Y.
    Seki, M.
    Suzuki, S.
    Ito, K.
    Arakawa, H.
    LUMINESCENCE, 2008, 23 (02) : 90 - 90
  • [48] Protective effects of nitric oxide synthase 3 and soluble guanylate cyclase on the outcome of cardiac arrest and cardiopulmonary resuscitation in mice
    Nishida, Takefumi
    De Yu, Jia
    Minamishima, Shizuka
    Sips, Patrick Y.
    Searles, Robert J.
    Buys, Emmanuel S.
    Janssens, Stefan
    Brouckaert, Peter
    Bloch, Kenneth D.
    Ichinose, Fumito
    CRITICAL CARE MEDICINE, 2009, 37 (01) : 256 - 262
  • [49] Residues stabilizing the heme moiety of the nitric oxide sensor soluble guanylate cyclase
    Schmidt, PM
    Rothkegel, C
    Wunder, F
    Schröder, H
    Stasch, JP
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 513 (1-2) : 67 - 74
  • [50] Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits
    Filippov, G
    Bloch, DB
    Bloch, KD
    CIRCULATION, 1996, 94 (08) : 3050 - 3050